The outcome of left axillary, supraclavicual, and cervical chain lymphadenopathy > 1-week post-injection was not recovered and other events was unknown. It was also reported on Dec2020, "since the vaccination, has the patient been tested for COVID-19?: Yes". in which the patient received no treatment. The patient experienced left axillary, supraclavicual, and cervical chain lymphadenopathy > 1-week post-injection on 22Dec2020 16:00. The patient's concomitant medications were not reported. The patient medical history was not reported. A 26-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular on the left arm on 21Dec2020 20:00 at single dose for COVID-19 immunisation. since the vaccination, has the patient been tested for COVID-19?: Yes since the vaccination, has the patient been tested for COVID-19?: Yes This is a spontaneous report from a contactable healthcare professional. Left axillary, supraclavicual, and cervical chain lymphadenopathy > 1-week post-injection. He reports noticing a (L) supraclavicular nodule about 1-2 days ago Immune system & inflammation symptom reports Male, 26 - 39 years Age
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |